|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
copanlisib results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:31445927 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Fas |
Fas cell surface death receptor |
affects response to substance |
ISO |
copanlisib affects the susceptibility to FAS protein |
CTD |
PMID:31445927 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Tnf |
tumor necrosis factor |
increases response to substance |
ISO |
copanlisib results in increased susceptibility to TNF protein |
CTD |
PMID:31445927 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
ricolinostat promotes the reaction [Bortezomib results in increased cleavage of CASP3 protein] |
CTD |
PMID:22262760 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
ricolinostat promotes the reaction [Bortezomib results in increased cleavage of CASP8 protein] |
CTD |
PMID:22262760 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[ricolinostat co-treated with Bortezomib] results in increased cleavage of CASP9 protein |
CTD |
PMID:22262760 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions increases phosphorylation |
ISO |
Bortezomib promotes the reaction [ricolinostat results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:22262760 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases phosphorylation |
ISO |
Bortezomib affects the reaction [ricolinostat results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:22262760 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions affects phosphorylation |
ISO |
Bortezomib affects the reaction [ricolinostat affects the phosphorylation of ERN1 protein] |
CTD |
PMID:22262760 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esrra |
estrogen related receptor, alpha |
decreases expression |
ISO |
ricolinostat results in decreased expression of ESRRA protein |
CTD |
PMID:34524571 |
|
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
|
|
G |
Hdac6 |
histone deacetylase 6 |
decreases activity |
ISO |
ricolinostat results in decreased activity of HDAC6 protein |
CTD |
PMID:22262760 PMID:34524571 |
|
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
ricolinostat promotes the reaction [Bortezomib results in increased cleavage of PARP1 protein] |
CTD |
PMID:22262760 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
ISO |
[ricolinostat co-treated with Bortezomib] results in increased expression of XBP1 protein alternative form |
CTD |
PMID:22262760 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|